Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (Q37349242)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 July 2009
edit
Language Label Description Also known as
English
Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults
scientific article published on 15 July 2009

    Statements

    Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults (English)
    Clayton Harro
    Xiao Sun
    Jon E Stek
    Randi Y Leavitt
    Devan V Mehrotra
    Fubao Wang
    Andrew J Bett
    Danilo R Casimiro
    John W Shiver
    Mark J DiNubile
    Erin Quirk
    Merck V526-001 Study Group
    15 July 2009
    1285-1292

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit